East Brunswick, NJ, United States of America

Ashish Chatterji

This inventor holds 9 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Kashiv Specialty Pharmaceuticals, LLC, Kashiv Biosciences, LLC, Amneal Complex Products Research LLC. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashish Chatterji. Retrieved from https://idiyas.com/inventor/ashish-chatterji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 17)

% Patents Active = 77.8

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Bridgewater, NJ (US) (2020)
East Brunswick, NJ (US) (2012 - 2024)

Company Filing History:

3 out of 10

Kashiv Specialty Pharmaceuticals, LLC

patents

2 out of 22

Kashiv Biosciences, LLC

patents

1 out of 13

Amneal Complex Products Research LLC

patents

4. 1 out of 34

Asana Biosciences, LLC

patents

5. 1 out of 5,024

Hoffmann-La Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12042559 - Gastroretentive dosage forms for sustained drug delivery (2024-07-23),

2. 11318091 - Gastroretentive dosage forms for sustained drug delivery (2022-05-03),

3. 11007145 - Gastroretentive dosage forms for sustained drug delivery (2021-05-18),

4. 10918597 - Gastroretentive dosage forms for sustained drug delivery (2021-02-16),

5. 10857098 - Gastroretentive dosage forms for sustained drug delivery (2020-12-08),

6. 10744131 - Abuse-resistant drug formulations (2020-08-18),

7. 10695296 - Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient (2020-06-30),

8. 10632113 - Abuse-resistant drug formulations with built-in overdose protection (2020-04-28),

9. 8222230 - Pharmaceutical compositions with superior product performance and patient compliance (2012-07-17),

Title: The Innovative Contributions of Ashish Chatterji

Introduction

Ashish Chatterji is a notable inventor based in East Brunswick, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has made remarkable advancements in drug delivery systems.

Latest Patents

Among his latest patents is the development of gastroretentive dosage forms for sustained drug delivery. This innovation focuses on floating gastroretentive dosage forms that provide prolonged gastric residence time. The patent also includes rapidly expanding sustained release or combined immediate release and sustained release formulations. These formulations are designed for drugs that require targeted release in the proximal gastrointestinal tract to achieve maximum therapeutic benefit. The rapidly expanding floating gastroretentive dosage forms feature a permeable elastic membrane that ensures optimal drug release characteristics and mechanical strength to maintain tablet integrity.

Career Highlights

Throughout his career, Ashish Chatterji has worked with prominent companies such as Kashiv Specialty Pharmaceuticals and Kashiv Biosciences. His work in these organizations has contributed to the advancement of pharmaceutical technologies and drug delivery systems.

Collaborations

Some of his notable coworkers include Navnit Hargovindas Shah and Dipen Desai, who have collaborated with him on various projects.

Conclusion

Ashish Chatterji's innovative work in gastroretentive dosage forms has significantly impacted the pharmaceutical industry. His contributions continue to enhance drug delivery systems, providing better therapeutic outcomes for patients.

Profile summary based on public USPTO records.